Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SR419 in Postherpetic Neuralgia
NCT05357677Phase 2Completed
- Sponsor
- Shanghai SIMRD Biotechnology Co., Ltd.
- Start
- May 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sr419 in postherpetic neuralgia (PHN), sponsored by Shanghai SIMRD Biotechnology Co., Ltd.. Started May 2022; status: completed.
02
Drugs
sr419
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT05357677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05357677.